ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.00%
Brent Oil
82.585
0.00%
Bitcoin
60,669.35
-0.21%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Evolus Inc (EOLS)

  7. Evolus Inc (EOLS) News

Evolus (EOLS)

Evolus Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EOLS
DateTimeSourceHeadlineSymbolCompany
10/05/202423:55Business WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
10/05/202414:10Business WireEvolus’ Sandra Beaver Named Orange County Business Journal’s Public Company CFO of the YearNASDAQ:EOLSEvolus Inc
07/05/202422:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EOLSEvolus Inc
07/05/202421:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EOLSEvolus Inc
07/05/202421:05Business WireEvolus Reports First Quarter 2024 Results and Provides Business UpdateNASDAQ:EOLSEvolus Inc
23/04/202421:30Business WireEvolus to Report First Quarter Financial Results on May 7, 2024NASDAQ:EOLSEvolus Inc
17/04/202421:05Business WireEvolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®NASDAQ:EOLSEvolus Inc
12/04/202421:05Business WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
26/03/202412:00Business WireEvolus to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:EOLSEvolus Inc
11/03/202413:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EOLSEvolus Inc
11/03/202411:00Business WireEvolus Announces Pricing of $50.0 Million Underwritten Offering of Common StockNASDAQ:EOLSEvolus Inc
08/03/202421:05Business WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
07/03/202421:58Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:EOLSEvolus Inc
07/03/202421:42Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:EOLSEvolus Inc
07/03/202421:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EOLSEvolus Inc
07/03/202421:05Business WireEvolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 GuidanceNASDAQ:EOLSEvolus Inc
01/03/202413:30Business WireEvolus Announces Results from European Head-to-Head Filler TrialNASDAQ:EOLSEvolus Inc
27/02/202413:30Business WireEvolus to Participate in Upcoming Leerink Partners and Barclays Investor ConferencesNASDAQ:EOLSEvolus Inc
24/02/202401:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
24/02/202401:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
22/02/202421:30Business WireEvolus to Report Fourth Quarter and Year End 2023 Results and Provide Business Update on March 7, 2024NASDAQ:EOLSEvolus Inc
09/02/202423:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
09/02/202423:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
09/02/202423:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
09/02/202423:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
09/02/202423:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
09/02/202423:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
09/02/202421:05Business WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
02/02/202421:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
30/01/202421:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EOLSEvolus Inc
 Showing the most relevant articles for your search:NASDAQ:EOLS

Your Recent History

LSE
PET
Petrel Resources
LSE
TERN
Tern
LSE
VAST
Vast Resources
LSE
AGL
Angle
LSE
POS
Plexus
LSE
OXB
Oxford Biomedica
LSE
GKP
Gulf Keystone Petroleum
LSE
SYME
Supply@me Capital
LSE
ITV
Itv
LSE
PANR
Pantheon Resources
LSE
RKH
Rockhopper Exploration
LSE
SRSP
Sirius Petroleum
LSE
GOLD
LSE
SCLP
Scancell
LSE
TXP
Touchstone Exploration
LSE
SCE
Surface Transforms
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved